Palisade Bio Inc. (PALI)
Palisade Bio Statistics
Share Statistics
Palisade Bio has 4.4M shares outstanding. The number of shares has increased by 369.53% in one year.
| Shares Outstanding | 4.4M |
| Shares Change (YoY) | 369.53% |
| Shares Change (QoQ) | 58.95% |
| Owned by Institutions (%) | 17.25% |
| Shares Floating | 4.36M |
| Failed to Deliver (FTD) Shares | 3.43K |
| FTD / Avg. Volume | 1.13% |
Short Selling Information
The latest short interest is 176.38K, so 3.84% of the outstanding shares have been sold short.
| Short Interest | 176.38K |
| Short % of Shares Out | 3.84% |
| Short % of Float | 4.03% |
| Short Ratio (days to cover) | 1.3 |
Valuation Ratios
The PE ratio is -0.16 and the forward PE ratio is -0.56. Palisade Bio's PEG ratio is 0.
| PE Ratio | -0.16 |
| Forward PE | -0.56 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.31 |
| P/FCF Ratio | -0.19 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Palisade Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.24 |
| Quick Ratio | 3.24 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 1238.25 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-1.8M |
| Employee Count | 8 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -88.12% in the last 52 weeks. The beta is 1.38, so Palisade Bio's price volatility has been higher than the market average.
| Beta | 1.38 |
| 52-Week Price Change | -88.12% |
| 50-Day Moving Average | 0.8 |
| 200-Day Moving Average | 2.38 |
| Relative Strength Index (RSI) | 48.61 |
| Average Volume (20 Days) | 305.03K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -14.86M |
| Net Income | -14.44M |
| EBITDA | -14.86M |
| EBIT | -14.45M |
| Earnings Per Share (EPS) | -10.19 |
Balance Sheet
The company has 9.82M in cash and 90K in debt, giving a net cash position of 9.73M.
| Cash & Cash Equivalents | 9.82M |
| Total Debt | 90K |
| Net Cash | 9.73M |
| Retained Earnings | -135.94M |
| Total Assets | 10.88M |
| Working Capital | 7.26M |
Cash Flow
In the last 12 months, operating cash flow was -12.19M and capital expenditures 0, giving a free cash flow of -12.19M.
| Operating Cash Flow | -12.19M |
| Capital Expenditures | 0 |
| Free Cash Flow | -12.19M |
| FCF Per Share | -8.61 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PALI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PALI is $23, which is 3008.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $23 |
| Price Target Difference | 3008.1% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Apr 8, 2024. It was a backward split with a ratio of 1:15.
| Last Split Date | Apr 8, 2024 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -20.52 |
| Piotroski F-Score | 3 |